Evidence map›Paper›PMID 40207815›Full record

ArticleCurrent Alzheimer research2025

Analysis of the Relationship Between NLRP3 and Alzheimer's Disease in Oligodendrocytes based on Bioinformatics and

Chen Li, Yan Chen, Yinhui Yao, Yuxin Zhang, Shu Tong, Yazhen Shang

Abstract read
PubMed Publisher
In one paragraph

Article in Current Alzheimer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen LiInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.
Yan ChenInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.
Yinhui YaoInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.
Yuxin ZhangInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.
Shu TongInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.
Yazhen ShangInstitute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, China.

Funding

Hebei Provincial Administration of Traditional Chinese Medicine 05027, 2014062Hebei Provincial Education Department ZD20131022, ZD2019057Hebei Provincial Natural Science Foundation H2019406063Key Subject of Pharmacology of Traditional Chinese Medicine of Hebei Province Traditional Chinese Medicine [2021] 7Science and Technology Innovation Team Construction Project of Chengde Medical College of China [2020] 50
6 · The paper itself

Abstract

aimsThis study aims to explore the potential association between nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) in oligodendrocytes and Alzheimer's disease (AD), utilizing a combination of bioinformatics analysis and molecular biology experiments to validate this relationship.

methodsPublic datasets related to AD were systematically retrieved and downloaded from the Gene Expression Omnibus (GEO) database at the National Center for Biotechnology Information (NCBI). Subsequently, the SVA package was employed to merge the data and eliminate batch effects, allowing for the precise identification of differentially expressed genes (DEGs) between AD patients and healthy controls. Advanced machine learning techniques, including LASSO regression analysis, random forest algorithms, and support vector machines (SVM), were utilized to analyze further the DEGs associated with the NLRP3 inflammasome to determine the gene set most closely related to AD. The effectiveness and clinical value of the gene-based diagnostic model were comprehensively assessed through receiver operating characteristic (ROC) curve analysis, nomogram construction, and decision curve analysis (DCA). Immune infiltration analysis evaluated the extent of various immune cell infiltrations in the brain tissue of AD patients. Single-cell transcriptomics and

resultsA total of 11 significant DEGs were identified, with 4 genes showing downregulation and 7 genes exhibiting upregulation. All three algorithms-LASSO regression, random forest, and SVM-consistently identified PANX1, APP, P2RX7, MEFV, and NLRP3 as key genes closely associated with AD. ROC curve analysis, nomogram modeling, and DCA results demonstrated that the diagnostic model constructed based on these five genes exhibited high diagnostic accuracy and clinical applicability. Immune infiltration analysis revealed a significant correlation between key genes associated with AD and various immune cells, particularly CD8+ T cells, monocytes, activated NK cells, and neutrophils, suggesting that these cells may play important roles in the immunopathological process of AD. Single-cell transcriptomics indicated that the expression level of NLRP3 in oligodendrocytes was higher in the AD group compared to the control group (p < 0.05). Additionally,

conclusionThis study corroborates the high expression of NLRP3 in AD and its close relationship with the disease through integrated bioinformatics analysis and molecular biology experiments. Furthermore, the diagnostic model constructed based on the five key genes-PANX1, APP, P2RX7, MEFV, and NLRP3-not only provides a robust tool for early diagnosis of AD but also offers new insights for the development of treatment targets for AD.

Indexed as

Alzheimer DiseaseComputational BiologyNLR Family, Pyrin Domain-Containing 3 ProteinOligodendrogliaGene Expression ProfilingHumansMaleNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanAlzheimer's diseasebioinformaticsLASSONLRP3oligodendrocytesrandom forestsupport vector machines.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.